JA
CYTK icon

JOYN Advisors’s Cytokinetics CYTK Stock Holding History

JOYN Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-554
Closed -$4K – 417
2018
Q4 		$4K Sell
554
-272
-33% -$2K ﹤0.01% 1297
2018
Q3 		$8K Sell
826
-148
-15% -$1.19K ﹤0.01% 1022
2018
Q2 		$8K Buy
974
+857
+732% +$7.13K ﹤0.01% 980
2018
Q1 		$1K Buy
+117
New +$1K ﹤0.01% 1166

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

JOYN Advisors's CYTK Position: Q1 2019 in Review

JOYN Advisors sold out of Cytokinetics (CYTK) in Q1 2019, closing a stake of 554 shares — an estimated $4K sold.

JOYN Advisors first reported a position in CYTK in Q1 2018 and held it in 4 quarters. The position peaked at $8K in Q3 2018. 138 funds tracked by Wall St. Rank hold CYTK as of Q1 2019.

  • JOYN Advisors reported no remaining Cytokinetics position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 554 Cytokinetics shares in Q1 2019, an estimated $4K.
  • JOYN Advisors first reported a position in Cytokinetics in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Cytokinetics position peaked at $8K in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.